BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Receivables

Track TNF Pharmaceuticals's receivables ($17K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$16800.00
↑ 576.87% YoYΔ $14318.00 vs prior year quarter

Peer trimmed avg / median

Loading

TNF Pharmaceuticals Receivables History

Loading

TNF Pharmaceuticals vs. peers: Receivables Comparison

Loading

TNF Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

TNF Pharmaceuticals posts a receivables of $17K as of March 2026. That compares with $2.5K in the prior-year period — up 576.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, TNF Pharmaceuticals's receivables was $2.5K. The latest reading is $17K — a 576.9% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of TNF Pharmaceuticals's financial statement story. At $17K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TNFA's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; TNF Pharmaceuticals's other metric pages and overview cover the third.